Emerging Therapeutic Segments in the European Biopharmaceutical Markets

Abstract

The research services provides an analysis of the European markets for emerging therapeutic areas such as antisense therapy, gene therapy and cell therapy. The research services segments the market based on the drug classes. The research analyses the challenges faced by the biopharmaceutical industry and the potential uses for the emerging therapeutic areas. The research also provides market sizes for the total biopharmaceutical markets and the market for emerging therapeutic areas.